View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

MM Group Industrial & International Trade (In Kind): 1 director

A director at MM Group Industrial & International Trade (In Kind) bought 100,150 shares at 0.000EGP and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...

Dassault Systemes Sa: 1 director

A director at Dassault Systemes Sa bought 40,000 shares at 37.816EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Talanx AG: 1 director

A director at Talanx AG bought 400 shares at 71.275EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

Alliance Trust PLC - Net Asset Value

Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC                 At the close of business Monday 20 May 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 1279.3p                 -       including income, 1287.1p   The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income, 1283.3p -       including income, 1291.1p For further information, please contact: -  Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in acc...

Arab Cotton Ginning: 1 director

A director at Arab Cotton Ginning bought 1,258,582 shares at 0.000EGP and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

Rakta Paper Manufacturing: 1 director

A director at Rakta Paper Manufacturing bought 46,269 shares at 0.000EGP and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

International Co For Investment & Development: 1 director

A director at International Co For Investment & Development bought 585,841 shares at 0.000EGP and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

Kitron ASA: 1 director

A director at Kitron ASA bought 10,765 shares at 31.740NOK and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Arab Dairy Products Co Arab Dairy Panda: 1 director

A director at Arab Dairy Products Co Arab Dairy Panda bought 1,018,409 shares at 0.000EGP and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...

Atlas for Investment & Food Industries SAE: 1 director

A director at Atlas for Investment & Food Industries SAE bought 5,581,872 shares at 0.000EGP and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...

 PRESS RELEASE

Purple Biotech Reports First Quarter 2024 Financial Results

Purple Biotech Reports First Quarter 2024 Financial Results CM24 Phase 2 Pancreatic Cancer Interim Data Selected for Late Breaking Abstract Poster Presentation at ASCO 2024 – Interim results to be Announced June 1, 2024 REHOVOT, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the three months ended March 31, 2024. “We look forward to...

 PRESS RELEASE

Mattr Reports Voting Results From Annual Meeting

Mattr Reports Voting Results From Annual Meeting TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held virtually on May 15, 2024. A total of 49,829,154 common shares were voted at the meeting representing 75.11% of the votes attached to all outstanding shares. Shareholders voted in favour of all items of business before the meeting, including the election of all director nominees as follows: Name of Nominee% of Votes For% of Votes ...

 PRESS RELEASE

Else Nutrition Adds New Product Listings at Hundreds of Locations of W...

Else Nutrition Adds New Product Listings at Hundreds of Locations of World’s Largest Retailer Retail giant will add Else’s New Ready-to-Drink Kids Shakes at ~ 600 new locations Else Nutrition witnessing success on retailer’s online platform with sales rapidly increasing VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. () () () ("Else" or the "Company"), is proud to announce that the world’s largest retailer will be adding additional Else’s product listings to hundreds of stores. Else Ready-to-Drink Kids Shakes (Chocolate and Vanilla): Adding...

 PRESS RELEASE

Correction: The Board of Directors of Eezy Plc has resolved to change ...

Correction: The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employees EEZY PLC -- STOCK EXCHANGE RELEASE – 21 MAY 2024 AT 14:30 PM Correction: The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employees Eezy Plc corrects its stock exchange release about changes to the target levels of the performance...

 PRESS RELEASE

Korjaustiedote: Eezy Oyj:n hallitus päätti yhtiön avainhenkilöille suu...

Korjaustiedote: Eezy Oyj:n hallitus päätti yhtiön avainhenkilöille suunnatun osakepalkkiojärjestelmän neljännen ansaintajakson ansaintakriteereiden tavoitetasojen muuttamisesta EEZY OYJ -- PÖRSSITIEDOTE – 21.5.2024 KLO 14:30 Korjaustiedote: Eezy Oyj:n hallitus päätti yhtiön avainhenkilöille suunnatun osakepalkkiojärjestelmän neljännen ansaintajakson ansaintakriteereiden tavoitetasojen muuttamisesta Eezy Oyj korjaa 20.5.2024 klo 13.30 julkistettua tiedotettaan koskien yhtiön avainhenkilöille suunnatun osakepalkkiojärjestelmän neljännen ansaintajakson ansaintakriteereiden tavoitetasojen muu...

 PRESS RELEASE

John J. Fawcett Appointed to Bread Financial™’s Board of Directors

John J. Fawcett Appointed to Bread Financial™’s Board of Directors COLUMBUS, Ohio, May 21, 2024 (GLOBE NEWSWIRE) -- (NYSE: BFH) today announced that John J. Fawcett, a seasoned financial services executive, has joined the Company’s board as an independent director. Mr. Fawcett was elected at the Company's Annual Meeting of Stockholders, held Tuesday, May 14, along with nominees Ralph J. Andretta, Roger H. Ballou, John C. Gerspach, Jr., Rajesh Natarajan, Joyce St. Clair, Timothy J. Theriault, Laurie A. Tucker and Sharen J. Turney, each of whom served as Bread Financial directors during th...

 PRESS RELEASE

Intermap’s Real 3D Data Elevates Video Game Development

Intermap’s Real 3D Data Elevates Video Game Development Enhancing in-game realism with real 3D mapping Streamlining design processes for the creation of gaming environments DENVER, May 21, 2024 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced a contract with one of the top 5 video game developers to provide custom digital surface models (DSMs) for the creation of realistic in-game environments. By leveraging Intermap’s NEXTMap® 3D DSMs, vide...

 PRESS RELEASE

Brixton Metals Commences its Fully Funded 2024 Drill Season at its Tho...

Brixton Metals Commences its Fully Funded 2024 Drill Season at its Thorn Copper-Gold Porphyry Project Three New Copper Targets to Be Drill Tested VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce that its Thorn exploration camp is now open for the season and drilling has commenced. Brixton is fully funded for the 2024 exploration program with plans to drill test several new copper porphyry targets, including the Trifecta, Cirque, and North Copper Targets, in addition to ...

 PRESS RELEASE

Cognition Therapeutics Releases New Episode of “Conversations” Podcast...

Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease PURCHASE, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released its eighth Conversations video podcast episode: “Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease.” This episode reviews how beta amyloid (Aβ) oligomers cause synaptic dysfunction, which is correlated with cognitive decline. This conversation ...

 PRESS RELEASE

Annovis Announces New Publication in a Peer-Reviewed Journal

Annovis Announces New Publication in a Peer-Reviewed Journal MALVERN, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article focused on the comparison of pharmacokinetic profiles of Posiphen (or buntanetap) across different species in a peer-reviewed journal Biomolecules as part of the . “This publication is a testament to many years of research at Annovis. While we have conducted numerous studies to advan...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch